以下特刊的文章以前发表过，可以在相应的网络版上找到

IF 2.9 3区医学 Q2 CLINICAL NEUROLOGY

Acta Neurologica Scandinavica Pub Date : 2022-09-26 DOI:10.1111/ane.13714

引用次数: 0

摘要

阿尔茨海默病和相关疾病的血液生物标志物(146:1)https://doi.org/10.1111/ane.13628

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

The following article for the special issue were previously published and can be found in its respective issue online

Blood biomarkers for Alzheimer's disease and related disorders (146:1) https://doi.org/10.1111/ane.13628

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Acta Neurologica Scandinavica 医学-临床神经学

CiteScore

6.70

自引率

2.90%

发文量

161

审稿时长

4-8 weeks

期刊介绍： Acta Neurologica Scandinavica aims to publish manuscripts of a high scientific quality representing original clinical, diagnostic or experimental work in neuroscience. The journal''s scope is to act as an international forum for the dissemination of information advancing the science or practice of this subject area. Papers in English will be welcomed, especially those which bring new knowledge and observations from the application of therapies or techniques in the combating of a broad spectrum of neurological disease and neurodegenerative disorders. Relevant articles on the basic neurosciences will be published where they extend present understanding of such disorders. Priority will be given to review of topical subjects. Papers requiring rapid publication because of their significance and timeliness will be included as ''Clinical commentaries'' not exceeding two printed pages, as will ''Clinical commentaries'' of sufficient general interest. Debate within the speciality is encouraged in the form of ''Letters to the editor''. All submitted manuscripts falling within the overall scope of the journal will be assessed by suitably qualified referees.